29.11.2022 - 01.12.2022Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 to 16:30
Kongressthemen The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R and D landscape.
Speakers: Alan Watt, Chief Scientific Officer, NodThera, Bruno Reversade, Professor and Director, Laboratory of Human Genetics and Therapeutics GIS and IMCB, A*STAR, and more.